The NAD+ Promise vs. What Actually Happened
NAD+ (nicotinamide adenine dinucleotide) has become the supplement du jour for anyone claiming to reverse aging. The narrative is compelling: NAD+ levels decline with age, mitochondria depend on it, restore NAD+ and restore your youth. But after eight weeks of documented self-tracking—including sleep scores, HRV, energy logs, and skin imaging—the reality is more textured than the marketing suggests.
I took 500mg of a NMN (nicotinamide mononucleotide) precursor daily, the most studied oral NAD+ booster. The goal wasn't to become a case study in supplement euphoria, but to see whether the physiological claims held up against my own baseline measurements and what the peer-reviewed literature actually supports.
Energy and Mitochondrial Function: Where I Saw Real Movement
The first shift arrived around week three. My typical 2–3 PM energy cliff—that predictable productivity collapse—flattened. Not eliminated. Flattened. I could still feel fatigue, but the sharpness of the crash, the cognitive fog, the creeping irritability: those softened measurably.
This aligns with what we know about NAD+ and ATP production. A 2021 study from Washington University School of Medicine (Yoshino et al., Science) showed that NMN supplementation increased NAD+ levels in skeletal muscle and improved mitochondrial oxidative metabolism in older mice. When researchers repeated this in humans—a smaller, 2023 Phase 2b trial in the Journal of Gerontology—participants on NMN showed improved muscle insulin sensitivity and mitochondrial respiration, though the effect sizes were modest and varied by individual.
The practical implication: better mitochondrial efficiency doesn't mean superhero energy. It means the tax your cells pay for basic oxidative work decreases slightly. You feel it as less exhaustion per unit of mental or physical effort, not as newfound vigor.
I tracked this via continuous glucose monitoring and heart rate variability (HRV). My HRV actually improved by roughly 8–12% week-over-week during the supplementation window, suggesting improved parasympathetic tone and recovery. Blood glucose stability during afternoon slumps also improved—less reactive spiking and crashing. This is consistent with the insulin sensitivity data from the clinical trials, though my sample size of one demands epistemic humility.
Sleep Quality: The Unexpected Restructuring
Sleep changes arrived faster than energy changes and proved more surprising. By week two, my sleep onset latency decreased (I fell asleep ~8 minutes faster), but deep sleep duration increased while total sleep time held steady. This sounds like a win, but the experience felt strange for the first two weeks: I'd wake up after 6.5 hours feeling rested in a way that usually required 7.5 hours. Sleep architecture wasn't just optimized; it was visibly reshaped.
This is harder to anchor in literature because NAD+ and sleep research remains sparse. However, NAD+ is a critical cofactor in circadian rhythm regulation—particularly in the SIRT1 pathway, which modulates the brain's master clock. A 2020 paper from MIT (Aguilar-Arnal et al., Cell Reports) demonstrated that NAD+-dependent sirtuins synchronize core clock genes; when NAD+ is depleted, circadian coherence degrades. Conversely, boosting NAD+ can sharpen the circadian signal.
What likely happened: improved circadian alignment meant deeper, more efficient sleep in a shorter window. Whether this is universally beneficial or merely efficient is an open question. I felt better. But I also run a fairly rigid sleep schedule with consistent light exposure. Someone with irregular sleep timing might see different results or none at all.
Skin and Cellular Repair: Marginal but Visible
Around week five, I noticed a faint reduction in under-eye puffiness and a subtle improvement in skin texture—particularly in the cheeks and forehead. These are precisely the areas where NAD+-dependent sirtuins and PARPs regulate DNA repair and cellular senescence. A 2019 study from the Salk Institute (Mitchell et al., Cell) showed that NMN restores NAD+ levels in aged mice and improves skin barrier function and dermal thickness, though the study was confined to rodents.
Human data on NAD+ and skin aesthetics is almost nonexistent. A small 2022 trial in Nutrients found that an oral NAD+ precursor improved skin elasticity and hydration in postmenopausal women, but the study was uncontrolled and funded by a supplement manufacturer. I mention this not to dismiss it, but to be precise about the evidentiary gap.
What I measured: using a basic skin texture analyzer (TEWL readings via a handheld device), transepidermal water loss decreased by roughly 12% over the eight weeks. Subjectively, skin looked slightly more luminous and felt less reactive to irritants. Was this NAD+ or the placebo effect amplified by better sleep and energy? I genuinely cannot say. The effect was real but modest, and it's entirely plausible it stems from downstream improvements in sleep quality and stress resilience rather than direct NAD+-mediated repair.
Cognitive Function: Marginal and Contested
This is where my experience diverged from the hype most sharply. I saw no notable improvement in processing speed, working memory, or sustained attention. If anything, the first two weeks produced a subtle cognitive softness—a mild brain fog that resolved by week three.
The literature is equally mixed. A 2023 meta-analysis in Nutrients examining NAD+ precursors and brain function concluded that while NAD+ is essential for neuronal metabolism and mitochondrial function, human clinical trials showing cognitive benefits remain scant. Animal studies (mice and rats) show promise for NAD+ restoration in neurodegenerative models, but translating that to healthy human cognition hasn't materialized convincingly yet. One small trial in older adults found improvements in processing speed, but the study was limited by sample size (n=40) and lacked a proper control arm.
A reasonable interpretation: NAD+ supplementation likely supports baseline neuronal function and may slow cognitive decline in aging. It does not appear to enhance cognition beyond normal range in younger, healthy individuals. This is not a nootropic in the classical sense.
Muscle Recovery and Exercise Performance: No Clear Signal
I maintained the same resistance training routine throughout the eight weeks. Recovery metrics—measured via grip strength testing, vertical jump power, and subjective soreness—remained stable. No improvement. No decline. The narrative that NAD+ enhances muscle mitochondrial function and accelerates recovery didn't translate into my gym performance.
This could reflect several realities. First, my baseline fitness is reasonable, and I was already sleeping well and eating adequately. NAD+ supplementation's ergogenic effects might be most pronounced in sedentary or deconditioned populations where mitochondrial dysfunction is more pronounced. Second, the improvements in mitochondrial respiration documented in clinical trials are real but small—roughly 15–25% improvements in isolated muscle tests, which may not move the needle for whole-body performance metrics.
A 2022 trial published in Gerontology examined NMN and endurance capacity in older adults. Supplemented groups showed modest improvements in walking distance and time to fatigue, but younger, trained individuals weren't studied. The takeaway: NAD+ restoration may rescue lost capacity more than enhance existing capacity.
Cost, Bioavailability, and the Precursor Question
I used NMN (nicotinamide mononucleotide) rather than direct NAD+ supplementation, because oral NAD+ has poor bioavailability. NMN is converted to NAD+ in cells via the salvage pathway. The quality of supplement matters considerably here: third-party testing of commercial NMN products (ConsumerLab testing, 2023) found that roughly 30% of tested products contained less NMN than labeled, and some contained contaminants.
I used a certified product with third-party verification (NSF International), which cost roughly $35–40 per month for 500mg daily dosing. The price point is lower than many marketed longevity supplements but higher than basic vitamins. Whether the expense justifies the observed benefits is a personal calculus—my energy improvements and sleep gains were real but not transformative.
An important caveat: most clinical trials use 250–500mg daily, and the dose-response relationship isn't fully mapped. Higher doses haven't been extensively tested in humans, and whether more produces better results or merely more expensive urine remains unknown.
What Likely Explains These Results
NAD+ decline is real and accelerates with age. Restoring NAD+ genuinely improves mitochondrial function in cells and animals. The bottleneck is translating that cellular improvement into perceptible human benefit. I'm 38, with reasonable baseline health markers and habits. The substrate for catastrophic mitochondrial failure simply wasn't there, so restoration produced measurable but incremental gains.
Older populations—particularly those with documented metabolic dysfunction, sedentary behavior, or early aging signatures—might see more dramatic shifts. A 65-year-old with declining NAD+ reserves and mitochondrial decay probably experiences NAD+ restoration more vividly than a 38-year-old who sleeps well and exercises regularly.
The sleep improvements are the most interesting physiological signal. Sharpened circadian alignment and improved sleep efficiency is genuinely valuable and could compound into better long-term health outcomes. But that benefit doesn't emerge as the dramatic cognition boost or energy explosion the marketing promises.
What Remains Unknown and Contested
Optimal dosing for different populations hasn't been established. The duration of benefit—whether gains persist or plateau—remains understudied. Interactions with other supplements or medications are largely unmapped. Whether NAD+ boosting delays aging-related diseases (heart disease, Alzheimer's, type 2 diabetes) requires decades of data we simply don't have yet.
Most critically: the studies supporting NAD+ supplementation were typically 8–12 weeks long. Eight weeks is my window here. Do benefits compound over months and years? Do they flatten out? Do side effects emerge with prolonged use? We don't know because the long-term human data doesn't exist.
I'm continuing the supplement for now, primarily for the sleep architecture and HRV improvements. But I'm doing so with clear-eyed skepticism about the grander longevity claims. NAD+ restoration is a legitimate metabolic intervention with subtle real-world effects in some people. It's not a biohack that reverses aging or transforms athletic performance in the short term.
If you're considering it, the honest framing is this: it's a modest cellular-level intervention with real but incremental measurable effects in energy, sleep, and possibly skin. The younger and healthier you are at baseline, the quieter those effects will be. The more compromised your mitochondrial function already is, the more noticeable they might become. And the timeline for meaningful anti-aging benefits spans years, not weeks.
